An Expanded Access Treatment Protocol of Zanidatamab (ZW25) in Patients With HER2-Positive Advanced Biliary Tract Cancer

NCT04578444 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

HER2-Positive Advanced Biliary Tract Cancer

Interventions

DRUG: Zanidatamab

Sponsor

Jazz Pharmaceuticals